|
|
||||||||
1From the University of New South Wales, Inflammation Research Unit, Department of Pathology, Sydney, New South Wales, Australia; and the 2Prince of Wales Hospital, Department of Ophthalmology, Sydney, New South Wales, Australia.
PURPOSE. Pterygia are common, frequently recurring ocular surface lesions characterized by tissue remodeling, cellular proliferation, angiogenesis, and inflammation. The increased incidence of pterygia in persons exposed to excessive solar radiation suggests that ultraviolet (UV) light may play a critical role in the pathogenesis of this disease. These investigations were focused on the expression of collagenase-1 (matrix metalloproteinase [MMP]-1) in pterygia and cultured pterygium epithelial cells, to determine whether the expression of this protease could be modified after exposure to UVB.
METHODS. Pterygium, conjunctival, and limbal epithelial cells were subcultured and exposed to various amounts of UVB. The conditioned medium and RNA were harvested for analysis by gelatin zymography, Western blot analysis, ELISA, and RT-PCR. Furthermore, whole pterygium specimens were irradiated to determine secreted MMP-1 levels.
RESULTS. Immunohistochemical analysis revealed enhanced MMP-1 expression in pterygia that corresponded precisely with p63-positive epithelial cells. In contrast, significantly less MMP-1 reactivity was found in normal conjunctiva, limbus, and cornea. A dose- and time-dependent increase in MMP-1 was observed when pterygium epithelial cells were exposed to UVB with no significant modulation of inhibitor activity. MMP-1 was not affected in irradiated normal conjunctival epithelial cells or in pterygium fibroblasts but was induced in limbal epithelial cells. Although the induction of MMP-1 after UVB was not mediated by an intermediate soluble factor, the extracellular signal-regulated kinase (ERK)1/2 mitogen-activated protein kinase (MAPK) intracellular pathway was involved.
CONCLUSIONS. Collectively, these data support the hypothesis of the involvement of UV light and MMPs in the development of pterygia and may assist in devising new therapeutic approaches for the treatment and prevention of pterygia.
This article has been cited by other articles:
![]() |
E. Peiretti, S. Dessi, C. Mulas, C. Abete, C. Norfo, M. Putzolu, and M. Fossarello Modulation of Cholesterol Homeostasis by Antiproliferative Drugs in Human Pterygium Fibroblasts Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3450 - 3458. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Kuo, D. Miyazaki, N. Nawata, T. Tominaga, A. Yamasaki, Y. Sasaki, and Y. Inoue Prognosis-Determinant Candidate Genes Identified by Whole Genome Scanning in Eyes with Pterygia Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3566 - 3575. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Di Girolamo, J. Chui, D. Wakefield, and M. T Coroneo Cultured human ocular surface epithelium on therapeutic contact lenses Br. J. Ophthalmol., April 1, 2007; 91(4): 459 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Di Girolamo, I. Indoh, N. Jackson, D. Wakefield, H. P. McNeil, W. Yan, C. Geczy, J. P. Arm, and N. Tedla Human Mast Cell-Derived Gelatinase B (Matrix Metalloproteinase-9) Is Regulated by Inflammatory Cytokines: Role in Cell Migration J. Immunol., August 15, 2006; 177(4): 2638 - 2650. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Di Girolamo, D. Wakefield, and M. T. Coroneo UVB-Mediated Induction of Cytokines and Growth Factors in Pterygium Epithelial Cells Involves Cell Surface Receptors and Intracellular Signaling. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2430 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A S Solomon Pterygium Br. J. Ophthalmol., June 1, 2006; 90(6): 665 - 666. [Full Text] [PDF] |
||||
![]() |
N. Di Girolamo, M. Coroneo, and D. Wakefield Epidermal Growth Factor Receptor Signaling Is Partially Responsible for the Increased Matrix Metalloproteinase-1 Expression in Ocular Epithelial Cells after UVB Radiation Am. J. Pathol., August 1, 2005; 167(2): 489 - 503. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |